Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
CONTEXT The European Association of Urology (EAU) panel on Non-muscle-invasive Bladder Cancer (NMIBC) released an updated version of the guidelines on Non-muscle-invasive Bladder Cancer. OBJECTIVE… Expand
Epidemiology and risk factors of urothelial bladder cancer.
CONTEXT Urothelial bladder cancer (UBC) is a disease of significant morbidity and mortality. It is important to understand the risk factors of this disease. OBJECTIVE To describe the incidence,… Expand
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
CONTEXT The first European Association of Urology (EAU) guidelines on bladder cancer were published in 2002 . Since then, the guidelines have been continuously updated. OBJECTIVE To present the… Expand
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
CONTEXT The European Association of Urology (EAU) Guidelines Panel on Upper Urinary Tract Urothelial Carcinoma (UTUC) has prepared updated guidelines to aid clinicians in the current evidence-based… Expand
European guidelines on upper tract urothelial carcinomas: 2013 update.
CONTEXT The European Association of Urology (EAU) guideline group for upper tract urothelial carcinoma (UTUC) has prepared updated guidelines to aid clinicians in assessing the current evidence-based… Expand
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
CONTEXT The European Association of Urology (EAU) guidelines panel on upper urinary tract urothelial cell carcinoma (UTUC) has prepared updated guidelines to aid clinicians in the current… Expand
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
CONTEXT This overview presents the updated European Association of Urology (EAU) guidelines for non-muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ (CIS). OBJECTIVE To provide… Expand
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
CONTEXT Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest… Expand
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
CONTEXT The natural history of renal cell carcinoma (RCC) is highly unpredictable. Small renal masses may be accompanied by metastatic disease. Conversely, patients with locally advanced disease may… Expand
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy.
CONTEXT Perioperative complications are a major surgical outcome for radical prostatectomy (RP). OBJECTIVE Evaluate complication rates following robot-assisted RP (RARP), risk factors for… Expand